Thu, Jul 24, 2014, 5:30 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Genomic Health Inc. Message Board

  • mdwhittier mdwhittier Sep 29, 2013 10:58 PM Flag

    Major Competitor(?)

    Thoughts anybody on FMI's recent IPO and the impact that FMI will have in this increasingly crowded space?

    While GHDX is the clear leader in the specific genomic tests for breast, colon and prostate cancer - to guide treatment decisions, the new competitor on the block is FMI. Looks like they could eat GHDX's lunch.

    I'm currently in a HOLD pattern with GHDX, but I'm aware that they could potentially lose their leadership position. Your thoughts, Terry?

    Sentiment: Hold

 
GHDX
26.65-0.84(-3.06%)Jul 24 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.